GDPR represents an “urgent threat” to the EU’s research leadership roleMore than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way Share XGDPR represents an “urgent threat” to the EU’s research leadership rolehttps://pharmaphorum.com/views-and-analysis/gdpr-represents-an-urgent-threat-to-the-eus-research-leadership-role/
Is disability the last bastion of the representation debate?From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and Share XIs disability the last bastion of the representation debate?https://pharmaphorum.com/views-and-analysis/is-disability-the-last-bastion-of-the-representation-debate/
NICE methods and process review aims to create fertile ground for innovationThe way NICE reviews new medicines is about to go through its biggest change in years – but Share XNICE methods and process review aims to create fertile ground for innovationhttps://pharmaphorum.com/views-and-analysis/nice-methods-and-process-review-aims-to-create-fertile-ground-for-innovation/
The hidden danger of isolated congenital aspleniaTEAM 4 Travis is an advocacy group with one objective – to ensure it doesn’t take an autopsy Share XThe hidden danger of isolated congenital aspleniahttps://pharmaphorum.com/patients/shining-a-light-on-the-hidden-danger-of-isolated-congenital-asplenia/
Research charity crisis affects the whole development ecosystemHopes that the UK government would step in to support charity-funded medical research were dashed when the sector Share XResearch charity crisis affects the whole development ecosystemhttps://pharmaphorum.com/r-d/research-charity-crisis-affects-the-whole-development-ecosystem/
Pharma must adapt to embrace the opportunities of a new-look NHSFundamental changes to the way the NHS is structured and funded are afoot – and pharma needs to Share XPharma must adapt to embrace the opportunities of a new-look NHShttps://pharmaphorum.com/views-and-analysis/pharma-must-adapt-to-embrace-the-opportunities-of-a-new-look-nhs/
How accidental advocacy is amplifying the GM1 voiceRare disease families need to stand up and be counted if they want things to change said mum Share XHow accidental advocacy is amplifying the GM1 voicehttps://pharmaphorum.com/views-and-analysis/rare-disease-advocacy-is-amplifying-the-gm1-voice/
Building a better future for people with rare diseases in all four UK nationsHow has rare disease care changed over the last few years? And what might we expect from the Share XBuilding a better future for people with rare diseases in all four UK nationshttps://pharmaphorum.com/views-analysis-patients/building-a-better-future-for-people-with-rare-diseases-in-all-four-uk-nations/
Common but not normal: It’s time to talk about maternal mental healthAs part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of Share XCommon but not normal: It’s time to talk about maternal mental healthhttps://pharmaphorum.com/views-analysis-patients/common-but-not-normal-its-time-to-talk-about-maternal-mental-health/
